Health Care [ 4/12 ] | Biotechnology [ 17/74 ]
NASDAQ | Common Stock
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS).
The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; Proteus, transforming proteomic research; and reagent kits and semiconductor chips for use with its instruments.
It is used in protein identification, protein variants, antibody characterization, biomarker identification, and post translational modification analysis applications.
The company has a collaboration with SkyWaterTechnology for the development of consumable for Proteus, that will enable simultaneous protein sequencing.
Quantum-Si incorporated was founded in 2013 is headquartered in Branford, Connecticut.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 23 | 223.00 K Increased by +N/A% | -24.73 M Increased by +30.87% | Decreased by -11.09 K% Decreased by N/A% |
| Jun 30, 23 | 205.00 K Increased by +N/A% | -25.57 M Increased by +26.15% | Decreased by -12.47 K% Decreased by N/A% |
| Mar 31, 23 | 254.00 K Increased by +N/A% | -18.00 M Increased by +58.34% | Decreased by -7.09 K% Decreased by N/A% |
| Dec 31, 22 | 0.00 Decreased by N/A% | -37.69 M Decreased by -28.09% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 22 | 0.00 Decreased by N/A% | -35.77 M Decreased by -97.71% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 22 | 0.00 Decreased by N/A% | -34.63 M Increased by +2.99% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 22 | 0.00 Decreased by N/A% | -43.21 M Decreased by -266.84% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 21 | 0.00 Decreased by N/A% | -29.42 M Decreased by -208.25% | Decreased by N/A% Decreased by N/A% |